Refresh

AstraZeneca Pharma India Ltd.

Price on BSE   22 Apr,15:44 LIVE
8,443.20
-11.20
(-0.13%)

© 2026 Rediff.com
  • Volume :
  • 562.00
  • Prev Close :
  • 8,454.40
  • Day's H/L (Rs.) :
  • 8,591.00 - 8,418.20
  • 52wk H/L (Rs.) :
  • 10,653.05 - 7,630.00
  • Mkt Cap (Rs. Cr) :
  • 21,108.00
Price on NSE   22 Apr,15:54 LIVE
8,440.00
-12.00
(-0.14%)

© 2026 Rediff.com
  • Volume :
  • 5,217.00
  • Prev Close :
  • 8,452.00
  • Day's H/L (Rs.) :
  • 8,595.50 - 8,422.00
  • 52wk H/L (Rs.) :
  • 10,691.00 - 7,551.50
  • Mkt Cap (Rs. Cr) :
  • 0.00

View more

Market News

Rare-Disease, Cancer Drugs Get Cheaper
Rediff.com   03 Feb 2026
Report Card - AstraZeneca Pharma India Ltd.
PE Ratios
182.37
EPS (Rs.)
46.30
Sales (Rs. Cr)
611.57
Face Value (Rs.)
2
Net Profit Margin(%)
6.74
Last Bonus
1:1
Last Dividend(%)
1600
Return on Average Equity
15.02

News for AstraZeneca Pharma India Ltd.

Aurobindo Pharma Gets USFDA Nod for Dapagliflozin
Aurobindo Pharma receives USFDA approval for generic dapagliflozin tablets (5mg & 10mg) to control blood sugar in type 2 diabetes.
Apr 07, 2026 19:37
Alembic Pharma Gets USFDA Nod for Dapagliflozin
Alembic Pharmaceuticals receives USFDA approval for generic dapagliflozin tablets (5mg & 10mg) to control blood sugar in type-2 diabetes.
Apr 07, 2026 12:51
AstraZeneca Imfinzi Approved in India for Endometrial Cancer
AstraZeneca Pharma India gets approval to market Imfinzi (Durvalumab) for advanced endometrial cancer treatment in India.
Feb 10, 2026 14:05
AstraZeneca Durvalumab Approved for Gastric Cancer
CDSCO approves AstraZeneca's Durvalumab with chemotherapy for gastric/gastroesophageal junction cancer treatment in India.
Feb 04, 2026 14:19
Starmer Secures UK-China Export & Investment Deals
PM Starmer concludes China visit with multi-billion pound export and investment deals, boosting UK-China relations and trade.
Jan 31, 2026 18:27

More News for AstraZeneca Pharma India Ltd. »

News for Pharmaceuticals and health care

Reckitt Sees Double-Digit Growth in India Q1
Reckitt reports double-digit growth in India for Q1 2026, driven by Dettol, Durex, and expanded coverage. Emerging markets fuel growth.
Apr 22, 2026 23:55
Tata Power EZ Home Solutions Launched in Hyderabad
Tata Power launches EZ Home Solutions in Hyderabad, offering smart home technologies for lighting, security, and energy management.
Apr 22, 2026 22:14
TDIP Scheme: Boost for India Telecom Tech
DoT releases revised TDIP guidelines to boost India's telecom tech, 5G, 6G, and global standardization. Rs 203 crore outlay.
Apr 22, 2026 21:59
Redwood Software Opens Global Center in Hyderabad
Redwood Software inaugurates its global center in Hyderabad, India, focusing on AI-powered automation and expanding its workforce.
Apr 22, 2026 21:56
Vikash Lohia: Fastest Wealth Multiplier in India
Jupiter Wagons' Vikash Lohia tops wealth multiplier list among India Inc scions. Market cap increased 152.8 times in 6 years.
Apr 22, 2026 21:34

More News »

Top News

Reckitt Sees Double-Digit Growth in India Q1
Reckitt reports double-digit growth in India for Q1 2026, driven by Dettol, Durex, and expanded coverage. Emerging markets fuel growth.
Apr 22, 2026 23:55
Tata Power EZ Home Solutions Launched in Hyderabad
Tata Power launches EZ Home Solutions in Hyderabad, offering smart home technologies for lighting, security, and energy management.
Apr 22, 2026 22:14
Germany Appoints Honorary Consul in Ahmedabad
Germany appoints Abhay Kamal Mangaldas as honorary consul in Ahmedabad to strengthen ties with Gujarat, India.
Apr 22, 2026 22:11
TDIP Scheme: Boost for India Telecom Tech
DoT releases revised TDIP guidelines to boost India's telecom tech, 5G, 6G, and global standardization. Rs 203 crore outlay.
Apr 22, 2026 21:59
Redwood Software Opens Global Center in Hyderabad
Redwood Software inaugurates its global center in Hyderabad, India, focusing on AI-powered automation and expanding its workforce.
Apr 22, 2026 21:56

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com